Cargando…

Impact of microRNA-29b on nature killer cell in T-cell acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales:	Jin, Fengyan, Du, Zhonghua, Tang, Yang, Wang, Lixia, Yang, Yanping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681226/ https://www.ncbi.nlm.nih.gov/pubmed/33240418 http://dx.doi.org/10.3892/ol.2020.12273

Ejemplares similares

Impact of microRNA-29b on natural killer cells in T-cell acute lymphoblastic leukemia
por: Jin, Fengyan, et al.
Publicado: (2019)

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”
por: Silveira, André C., et al.
Publicado: (2018)

Aberrant splicing in B-cell acute lymphoblastic leukemia
por: Black, Kathryn L, et al.
Publicado: (2019)

Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia
por: Oliveira, Lucila H, et al.
Publicado: (2015)

MicroRNA regulation of natural killer cells
por: Sullivan, Ryan P., et al.
Publicado: (2013)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Allogenic natural killer cell immunotherapy of sizeable ovarian cancer: A case report
por: Xie, Silun, et al.
Publicado: (2017)

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
Publicado: (2013)

MicroRNA expression and activity in T-cell acute lymphoblastic leukemia
por: Ye, Fang
Publicado: (2017)

MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells
por: Miao, Fei, et al.
Publicado: (2021)

MicroRNA-218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2
por: Mu, Lijun, et al.
Publicado: (2022)

Corrigendum to “Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis”
por: Zhang, Hui, et al.
Publicado: (2017)

Corrigendum to ‘single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis’ [EBioMedicine 53 (2020) 102686]
por: Cai, Yi, et al.
Publicado: (2022)

Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]
Publicado: (2018)

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1
por: Li, Hong-Lin, et al.
Publicado: (2023)

MicroRNA-181a-5p functions as an oncogene in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018)

Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis
por: Liu, T, et al.
Publicado: (2014)

MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation
por: Meng, Cuida, et al.
Publicado: (2021)

MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma
por: Su, Zhengming, et al.
Publicado: (2020)

MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1
por: Wang, Ting, et al.
Publicado: (2023)

Transcriptome dynamics of the microRNA inhibition response
por: Wen, Jiayu, et al.
Publicado: (2016)

Role of Toll-like receptors in natural killer cell function in acute lymphoblastic leukemia
por: Gallardo‑Zapata, Janet, et al.
Publicado: (2021)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2011)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia
por: Gębarowska, Katarzyna, et al.
Publicado: (2021)

Natural Killer Cell Regulation by MicroRNAs in Health and Disease
por: Leong, Jeffrey W., et al.
Publicado: (2012)

Corrigendum to “Long Noncoding RNA TUG1/miR-29c Axis Affects Cell Proliferation, Invasion, and Migration in Human Pancreatic Cancer”
por: Lu, Yebin, et al.
Publicado: (2021)

Corrigendum to “Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma”
por: Dong, Shuling, et al.
Publicado: (2017)

MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia
por: Del Gaizo, Martina, et al.
Publicado: (2022)

Human peripheral blood-derived exosomes for microRNA delivery
por: Kang, Ji-Young, et al.
Publicado: (2019)

TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells
por: Lelaidier, Martin, et al.
Publicado: (2015)

Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
por: Colomar-Carando, Natalia, et al.
Publicado: (2022)

Evaluation of MicroRNA92, MicroRNA638 in Acute Lymphoblastic Leukemia of Egyptian Children
por: Fayed, Dina, et al.
Publicado: (2021)

microRNA-34a overexpression inhibits cell migration and invasion via regulating SIRT1 in hepatocellular carcinoma
por: Zhou, Jianhui, et al.
Publicado: (2019)

MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Corrigendum]
Publicado: (2021)

MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1
por: Wu, Deyao, et al.
Publicado: (2022)

[Corrigendum] Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells
por: Zhang, Wenqing, et al.
Publicado: (2023)

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vq9vvrmi9i7emkrdo5r61ta9rt